Scans

Tools

Home

Charts

Watchlist

Products

Archean Chemical Industries Ltd

ACI

NSE

₹479.75+0.24%19 Oct 2026

Reports

Chemicals Inorganic

Archean Chemical Industries Ltd

ACI

NSE

₹479.75

+0.24%

19 Oct 2026

SOICxStockScans Reports

Ask AI

Chemicals Inorganic

Indices

Business Overview: What the company does, in plain English.Growth Catalysts: The forward growth drivers and triggers.Guidance Report: Management guidance vs outcomes.Forensic Report: Accounting quality and red flags.Deep Dive Report: In-depth business analysis.

Archean Chemical Industries is a marine-chemicals company that extracts bromine, industrial salt and sulphate of potash from natural underground brine in the Rann of Kutch, using nothing more than the sun to evaporate and concentrate the brine - a structurally low-cost production method that few producers anywhere can match. Incorporated in 2009 and listed in 2022, the company has grown from a single-site brine processor into India’s largest exporter of both bromine and industrial salt, and it is now using the cash flows from that core operation to build downstream bromine-derivatives plants, acquire an oilfield-chemicals business, and place two strategic bets on the energy transition - silicon-carbide semiconductors and zinc-bromide batteries. The recurring pattern is vertical integration from a captive natural resource: every new engine is designed to consume the output of the one before it, moving further away from commodity pricing and closer to the end customer.

Business segments

Five engines at different stages - a marine-chemicals cash cow, two specialty-chemical platforms in ramp-up, and two advanced-materials bets under construction - each built with the cash flows of the one before.

1. Marine chemicals: the brine-to-bulk cash engine

Industrial salt and liquid bromine, extracted from captive brine reservoirs by solar evaporation, generate the export revenues that fund everything else - salt alone brings in roughly 70% of sales.

Captive brine, not purchased feedstock - the company draws brine from its own reservoirs in the Great Rann of Kutch, one of the world’s largest salt-marsh ecosystems, and concentrates it in solar evaporation ponds; that is how it achieves a cost position among the lowest globally for bromine and avoids the energy-intensive chemical routes most SOP producers rely on.
Industrial salt is the volume anchor - with 7.5 million metric tonnes of annual capacity and purity above 99.5% NaCl, the salt business serves only four or five chlor-alkali customers, all overseas, and the largest - Japanese trading house Sojitz - alone accounts for 60-65% of the segment’s revenue under long-term bilateral contracts.
Bromine is the specialty lever - from 42,000 tonnes of annual capacity, the company supplies more than 98% of India’s bromine exports to roughly 43 customers in pharmaceuticals, agrochemicals, flame retardants and water treatment, with a portion of output now reserved as captive feedstock for its own downstream derivatives plant.
SOP is the fixer-upper - as India’s only producer of natural sea-brine-based sulphate of potash, the company has 132,000 tonnes of capacity but shipped only 644 tonnes in the last fiscal year while it re-engineers the entire manufacturing process to resolve a salt-contamination problem that had suppressed output for several years.
The site itself is a moat - the integrated Hajipir facility sits close to Jakhau Jetty and Mundra Port in Gujarat, runs on hybrid renewable power that has cut coal burn by roughly 1,500 tonnes a month, and operates a zero-liquid-discharge system so no effluent leaves the plant.

2. Bromine derivatives: converting captive bromine into higher-margin specialties

A wholly owned subsidiary takes bromine from the parent’s tanks and turns it into clear brine fluids for oil drilling, PTA catalysts for polyester, and flame retardants - same molecule, better price.

Fed by the parent’s bromine expansion - the 14,000 tonnes of bromine capacity added in 2023 was built specifically to supply this plant, so Acume Chemicals buys its key raw material at cost rather than at merchant-market prices, giving it a structural margin advantage over standalone derivative producers.
Bought, not just built - the Jhagadia facility in Gujarat was commissioned in March 2024 with 18,000 tonnes of annual capacity across calcium bromide and brominated catalysts, and it is still ramping up, running at about 45% utilisation while customer trials and global approvals progress.
Early traction in oilfield and battery markets - one inorganic bromide has already been approved for use in batteries, zinc-bromide volumes are scaling for select customers, and the business has won acceptance at global oil-and-gas and agrochemical multinationals in the Middle East, Africa and India.

3. Oilfield chemicals: a distressed-asset revival with five plants

Acquired out of insolvency for ₹77 crore, Idealis Mudchemie gives Archean a ready-made platform in drilling fluids and mud chemicals - a customer overlap with the bromine-derivatives business that lets the group sell a fuller basket to oilfield service companies.

Five plants, three already running trials - the manufacturing footprint spans Gujarat, Andhra Pradesh and Tamil Nadu; three units have been commissioned and are dispatching samples to international customers, while a Gujarat plant awaits state approvals and the Nagri plant’s starch and PAC product roadmap is being redefined.
A reverse merger to simplify the structure - the wholly owned subsidiary, Idealis Chemicals Private Limited, is being amalgamated into another wholly owned subsidiary, Idealis Mudchemie Private Limited, leaving Archean with a cleaner chain of control and no change in its own shareholding.

4. Silicon-carbide semiconductors: India’s first commercial compound-semiconductor fab

Through step-down subsidiary SiCSem, Archean is building a ₹2,067-crore fabrication and packaging plant in Bhubaneswar that will make silicon-carbide power devices - the chips that go into electric vehicles, fast chargers and renewable-energy systems - with exclusive process technology from its UK partner.

Government-backed and the only one of its kind - the project is approved under the India Semiconductor Mission, a fiscal-support agreement was signed in May 2026, and SiCSem remains the sole compound-semiconductor fab-plus-ATMP project sanctioned under the programme.
Technology access through ownership - Archean holds roughly 22% of Clas-SiC Wafer Fab in the UK, a dedicated silicon-carbide foundry, securing exclusive rights to bring its proven fabrication processes to India; a Singapore R&D subsidiary and an on-site lab with IIT Bhubaneswar support the technology pipeline.
Capacity designed for domestic substitution - at full Phase 1 output, the plant will process 60,000 wafers a year and package 96 million units annually, targeting a market where India currently imports virtually all of its compound-semiconductor devices.

5. Zinc-bromide batteries: a bet on bromine-powered energy storage

Archean is the anchor investor in Offgrid Energy Labs, a US-based startup whose ZincGel flow battery runs on zinc-bromide chemistry - a direct vertical play that turns the company’s captive bromine into the electrolyte for long-duration grid storage.

Bromine from the Rann into the battery supply chain - with a roughly 18-21% stake acquired for about USD 12 million, Archean positions itself as the natural bromine supplier to a technology that uses zinc and bromine as its core materials, sidestepping the lithium, cobalt and nickel supply chains that dominate conventional batteries.
Designed for stationary storage, not cars - the ZincGel system claims roughly twice the cycle life of typical lithium-ion, about 90% round-trip efficiency, and the ability to discharge for 6-12 hours without significant degradation, making it suited to solar farms, microgrids and industrial peak-shaving.
Pilot first, giga-factory later - a 10 MWh pilot line is being set up in the UK, with the stated intention of building a large-scale manufacturing facility in India, where projected battery-storage demand exceeds 236 GWh by 2032.

Group structure and partners

The listed parent, Archean Chemical, sits above three wholly owned operating platforms and two step-down growth ventures, with strategic equity stakes in a UK semiconductor foundry and a US battery startup tying the new engines back to the core bromine resource.

Wholly owned operating subsidiaries - Acume Chemicals runs the bromine-derivatives plant at Jhagadia; Neun Infra holds the 70% stake in SiCSem and is the vehicle for energy-storage initiatives; Idealis Chemicals is being merged into Idealis Mudchemie.
Step-down operating entities - Idealis Mudchemie operates five oilfield-chemical plants; SiCSem is building the Bhubaneswar semiconductor fab; SiCSem Star in Singapore provides R&D and technology support for the SiC project.
Strategic equity partners - a 22% stake in Clas-SiC Wafer Fab (UK) secures exclusive SiC process technology for India; an 18-21% stake in Offgrid Energy Labs (US) anchors the zinc-bromide battery play.
Government and institutional relationships - the India Semiconductor Mission provides fiscal support for the SiCSem fab; IIT Bhubaneswar is building a ₹65-crore development lab inside the facility; the Gujarat government has signed an MoU for a captive 7-MMTPA salt jetty along the state’s coastline.

Quick Ratios

Quarterly Results

Profit & Loss

Balance Sheet

Cash Flow

Ratios

Peer Comparison

Quick Ratios

Quarterly Results

Profit & Loss

Balance Sheet

Cash Flow

Ratios

Peer Comparison

Price

Charts

Documents

Edit Ratios

Mkt Cap

Market Capitalization

₹5,900Cr

Close Price

₹477.90

Industry

Chemicals Inorganic

Price To Earnings

60.57

Price To Sales

5.29

Revenue

₹1,116Cr

Rev Gr TTM

Revenue Growth TTM

-0.43%

PAT Gr TTM

PAT Growth TTM

-39.27%

Consolidated

Standalone

Numbers

Percentage

Quarter	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue RevenueCr	290	413	284	213	240	242	346	292	233	255	301	327
Growth YoY Revenue Growth YoY%	-1.0	13.1	-25.8	-38.0	-17.2	-41.3	21.7	37.5	-3.0	5.1	-12.9	11.9
Expenses ExpensesCr	195	267	197	141	166	162	257	214	171	200	257	260
Operating Profit Operating ProfitCr	95	145	87	71	75	80	88	78	63	54	44	67
OPM OPM%	32.9	35.3	30.7	33.5	31.1	33.0	25.6	26.7	26.9	21.4	14.5	20.6
Other Income Other IncomeCr	11	9	12	10	-29	9	8	8	6	7	5	6
Interest Expense Interest ExpenseCr	2	2	2	2	3	3	0	5	6	4	10	5
Depreciation DepreciationCr	18	18	18	19	19	20	21	23	24	24	23	23
PBT PBTCr	87	135	80	61	23	66	75	58	40	33	16	44
Tax TaxCr	21	34	22	16	7	18	21	18	11	9	4	14
PAT PATCr	66	102	58	45	16	48	54	40	29	24	12	30
Growth YoY PAT Growth YoY%	3.8	3.5	-57.8	-52.2	-76.2	-52.9	-6.7	-10.5	84.5	-49.8	-77.3	-24.4
NPM NPM%	22.7	24.6	20.3	21.1	6.5	19.7	15.6	13.7	12.4	9.4	4.1	9.3
EPS EPS₹	5.4	8.2	4.7	3.6	1.3	3.9	4.3	3.3	2.4	1.9	1.1	2.5

Quarter	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue RevenueCr	290	413	284	213	240	242	346	292	233	255	301	327
Growth YoY Revenue Growth YoY%	-1.0	13.1	-25.8	-38.0	-17.2	-41.3	21.7	37.5	-3.0	5.1	-12.9	11.9
Expenses ExpensesCr	195	267	197	141	166	162	257	214	171	200	257	260
Operating Profit Operating ProfitCr	95	145	87	71	75	80	88	78	63	54	44	67
OPM OPM%	32.9	35.3	30.7	33.5	31.1	33.0	25.6	26.7	26.9	21.4	14.5	20.6
Other Income Other IncomeCr	11	9	12	10	-29	9	8	8	6	7	5	6
Interest Expense Interest ExpenseCr	2	2	2	2	3	3	0	5	6	4	10	5
Depreciation DepreciationCr	18	18	18	19	19	20	21	23	24	24	23	23
PBT PBTCr	87	135	80	61	23	66	75	58	40	33	16	44
Tax TaxCr	21	34	22	16	7	18	21	18	11	9	4	14
PAT PATCr	66	102	58	45	16	48	54	40	29	24	12	30
Growth YoY PAT Growth YoY%	3.8	3.5	-57.8	-52.2	-76.2	-52.9	-6.7	-10.5	84.5	-49.8	-77.3	-24.4
NPM NPM%	22.7	24.6	20.3	21.1	6.5	19.7	15.6	13.7	12.4	9.4	4.1	9.3
EPS EPS₹	5.4	8.2	4.7	3.6	1.3	3.9	4.3	3.3	2.4	1.9	1.1	2.5

Consolidated

Standalone

Numbers

Percentage

Financial Year	Mar 2019	Mar 2020	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
Revenue RevenueCr	566	608	1,130	1,441	1,330	1,041	1,081	1,116
Growth Revenue Growth%		7.5		27.5	-7.7	-21.7	3.9	-0.4
Expenses ExpensesCr	493	460	663	807	867	727	842	888
Operating Profit Operating ProfitCr	73	148	467	634	463	314	239	228
OPM OPM%	12.8	24.3	41.3	44.0	34.8	30.2	22.1	20.4
Other Income Other IncomeCr	122	9	12	43	43	-3	27	24
Interest Expense Interest ExpenseCr	118	122	162	97	8	8	26	26
Depreciation DepreciationCr	49	52	67	69	70	79	93	93
PBT PBTCr	27	-17	251	512	427	224	147	133
Tax TaxCr	-13	20	63	129	108	62	42	38
PAT PATCr	40	-36	188	383	319	162	105	96
Growth PAT Growth%		-190.7		103.3	-16.6	-49.2	-35.0	-39.3
NPM NPM%	7.1	-6.0	16.6	26.6	24.0	15.6	9.8	8.6
EPS EPS₹			18.2	34.7	25.9	13.1	8.7	7.9

Financial Year	Mar 2019	Mar 2020	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
Revenue RevenueCr	566	608	1,130	1,441	1,330	1,041	1,081	1,116
Growth Revenue Growth%		7.5		27.5	-7.7	-21.7	3.9	-0.4
Expenses ExpensesCr	493	460	663	807	867	727	842	888
Operating Profit Operating ProfitCr	73	148	467	634	463	314	239	228
OPM OPM%	12.8	24.3	41.3	44.0	34.8	30.2	22.1	20.4
Other Income Other IncomeCr	122	9	12	43	43	-3	27	24
Interest Expense Interest ExpenseCr	118	122	162	97	8	8	26	26
Depreciation DepreciationCr	49	52	67	69	70	79	93	93
PBT PBTCr	27	-17	251	512	427	224	147	133
Tax TaxCr	-13	20	63	129	108	62	42	38
PAT PATCr	40	-36	188	383	319	162	105	96
Growth PAT Growth%		-190.7		103.3	-16.6	-49.2	-35.0	-39.3
NPM NPM%	7.1	-6.0	16.6	26.6	24.0	15.6	9.8	8.6
EPS EPS₹			18.2	34.7	25.9	13.1	8.7	7.9

Consolidated

Standalone

Numbers

Percentage

Financial Year	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital Equity CapitalCr	19	25	25	25	25
Reserves ReservesCr	238	1,406	1,677	1,839	1,910
Current Liabilities Current LiabilitiesCr	176	172	135	197	438
Non Current Liabilities Non Current LiabilitiesCr	1,093	152	219	332	293
Total Liabilities Total LiabilitiesCr	1,531	1,755	2,056	2,393	2,665
Current Assets Current AssetsCr	399	577	726	691	531
Non Current Assets Non Current AssetsCr	1,133	1,179	1,330	1,702	2,133
Total Assets Total AssetsCr	1,531	1,755	2,056	2,393	2,665

Financial Year	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital Equity CapitalCr	19	25	25	25	25
Reserves ReservesCr	238	1,406	1,677	1,839	1,910
Current Liabilities Current LiabilitiesCr	176	172	135	197	438
Non Current Liabilities Non Current LiabilitiesCr	1,093	152	219	332	293
Total Liabilities Total LiabilitiesCr	1,531	1,755	2,056	2,393	2,665
Current Assets Current AssetsCr	399	577	726	691	531
Non Current Assets Non Current AssetsCr	1,133	1,179	1,330	1,702	2,133
Total Assets Total AssetsCr	1,531	1,755	2,056	2,393	2,665

Consolidated

Standalone

Financial Year	Mar 2019	Mar 2020	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Operating Cash Flow Operating Cash FlowCr	316	148	315	496	379	176	140
Investing Cash Flow Investing Cash FlowCr	-25	-197	-110	-290	-307	-246	-293
Financing Cash Flow Financing Cash FlowCr	-256	26	-224	-212	-33	65	154
Net Cash Flow Net Cash FlowCr	35	-23	-19	-6	40	-5	1
Free Cash Flow Free Cash FlowCr			218	397	249	-81	-242
CFO To PAT CFO To PAT%	791.1	-407.1	167.1	129.7	118.9	108.7	132.5
CFO To EBITDA CFO To EBITDA%	435.0	99.7	67.3	78.3	82.0	56.1	58.5

Financial Year	Mar 2019	Mar 2020	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Operating Cash Flow Operating Cash FlowCr	316	148	315	496	379	176	140
Investing Cash Flow Investing Cash FlowCr	-25	-197	-110	-290	-307	-246	-293
Financing Cash Flow Financing Cash FlowCr	-256	26	-224	-212	-33	65	154
Net Cash Flow Net Cash FlowCr	35	-23	-19	-6	40	-5	1
Free Cash Flow Free Cash FlowCr			218	397	249	-81	-242
CFO To PAT CFO To PAT%	791.1	-407.1	167.1	129.7	118.9	108.7	132.5
CFO To EBITDA CFO To EBITDA%	435.0	99.7	67.3	78.3	82.0	56.1	58.5

Consolidated

Standalone

Financial Year	Mar 2019	Mar 2020	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	Current
Valuation Ratios Valuation Ratios
Market Cap Market CapitalizationCr				8,007	8,269	6,362	7,244	5,900
Price To Earnings Price To Earnings				20.9	25.9	39.2	67.8	60.6
Price To Sales Price To Sales				5.6	6.2	6.1	6.7	5.3
Price To Book Price To Book				5.6	4.9	3.4	3.7	3.0
EV To EBITDA EV To EBITDA				12.7	18.0	20.8	32.1	27.7
Profitability Ratios Profitability Ratios
GPM GPM%			79.9	84.3	78.4	83.6	76.3	76.3
OPM OPM%	12.8	24.3	41.3	44.0	34.8	30.2	22.1	20.4
NPM NPM%	7.1	-6.0	16.6	26.6	24.0	15.6	9.8	8.6
ROCE ROCE%			35.7	40.6	24.2	11.1	7.2	7.2
ROE ROE%			73.0	26.7	18.8	8.7	5.5	5.5
ROA ROA%			12.3	21.8	15.5	6.8	4.0	4.0
Operational Ratios Operational Ratios
Solvency Ratios Solvency Ratios
Liquidity Ratios Liquidity Ratios

Financial Year	Mar 2019	Mar 2020	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	Current
Valuation Ratios Valuation Ratios
Market Cap Market CapitalizationCr				8,007	8,269	6,362	7,244	5,900
Price To Earnings Price To Earnings				20.9	25.9	39.2	67.8	60.6
Price To Sales Price To Sales				5.6	6.2	6.1	6.7	5.3
Price To Book Price To Book				5.6	4.9	3.4	3.7	3.0
EV To EBITDA EV To EBITDA				12.7	18.0	20.8	32.1	27.7
Profitability Ratios Profitability Ratios
GPM GPM%			79.9	84.3	78.4	83.6	76.3	76.3
OPM OPM%	12.8	24.3	41.3	44.0	34.8	30.2	22.1	20.4
NPM NPM%	7.1	-6.0	16.6	26.6	24.0	15.6	9.8	8.6
ROCE ROCE%			35.7	40.6	24.2	11.1	7.2	7.2
ROE ROE%			73.0	26.7	18.8	8.7	5.5	5.5
ROA ROA%			12.3	21.8	15.5	6.8	4.0	4.0
Operational Ratios Operational Ratios
Solvency Ratios Solvency Ratios
Liquidity Ratios Liquidity Ratios

	DEEPAKNTR	TANFACIND	ACI	JGCHEM	INDOBORAX	SRHHYPOLTD	GANESHBE
Market CapitalizationMkt CapCr	21,163	7,572	5,900	2,402	1,470	875	641
Close PriceClose₹	1,551.60	3,500.00	477.90	612.90	458.05	510.05	89.00
IndustryIndustry	Chemicals Inorganic	Chemicals Inorganic	Chemicals Inorganic	Chemicals Inorganic	Chemicals Inorganic	Chemicals Inorganic	Chemicals Inorganic
Price To EarningsPE	27.01	103.31	60.57	31.96	26.08	19.70	8.81
Price To SalesPS	2.47	10.48	5.29	2.24	6.33	1.25	1.48
RevenueRevenueCr	8,575	722	1,116	1,071	232	698	433
Revenue Growth TTMRev Gr TTM%	7.1%	13.3%	-0.4%	24.0%	29.7%	7.4%	13.3%
PAT Growth TTMPAT Gr TTM%	29.1%	-29.7%	-39.3%	16.6%	45.5%	0.6%	82.9%

	DEEPAKNTR	TANFACIND	ACI	JGCHEM	INDOBORAX	SRHHYPOLTD	GANESHBE
Market CapitalizationMkt CapCr	21,163	7,572	5,900	2,402	1,470	875	641
Close PriceClose₹	1,551.60	3,500.00	477.90	612.90	458.05	510.05	89.00
IndustryIndustry	Chemicals Inorganic	Chemicals Inorganic	Chemicals Inorganic	Chemicals Inorganic	Chemicals Inorganic	Chemicals Inorganic	Chemicals Inorganic
Price To EarningsPE	27.01	103.31	60.57	31.96	26.08	19.70	8.81
Price To SalesPS	2.47	10.48	5.29	2.24	6.33	1.25	1.48
RevenueRevenueCr	8,575	722	1,116	1,071	232	698	433
Revenue Growth TTMRev Gr TTM%	7.1%	13.3%	-0.4%	24.0%	29.7%	7.4%	13.3%
PAT Growth TTMPAT Gr TTM%	29.1%	-29.7%	-39.3%	16.6%	45.5%	0.6%	82.9%